DesRoches CM, Barrett KA, Harvey BE, Kogan R, Reschovsky JD, Landon BE, Casalino LP, Shortell SM, Rich EC.
2015.
The Results Are Only as Good as the Sample: Assessing Three National Physician Sampling Frames.. J Gen Intern Med. 30 Suppl 3:S595-601.
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al..
2016.
Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al..
2016.
Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.
Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al..
2016.
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.
Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al..
2016.
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.
Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank SV et al..
2020.
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.. J Clin Oncol. 38(13):1389-1397.
Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al..
2019.
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.
Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al..
2019.
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.
Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al..
2019.
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.
McDonough TL, Paolicchi JM, Heier LA, Das N, Engel M, Perlman JM, Grinspan ZM.
2017.
Prediction of Future Epilepsy in Neonates With Hypoxic-Ischemic Encephalopathy Who Received Selective Head Cooling.. J Child Neurol. 32(7):630-637.
Grinspan ZM, Shapiro JS, Abramson EL, Hooker G, Kaushal R, Kern LM.
2015.
Predicting frequent ED use by people with epilepsy with health information exchange data.. Neurology. 85(12):1031-8.
Hildick-Smith GJ, Pesko MF, Shearer L, Hughes JM, Chang J, Loughlin GM, Ipp LS.
2015.
A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population.. J Adolesc Health. 57(6):574-9.
Hildick-Smith GJ, Pesko MF, Shearer L, Hughes JM, Chang J, Loughlin GM, Ipp LS.
2015.
A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population.. J Adolesc Health. 57(6):574-9.
Jung H-Y, Unruh MAaron, Vest JR, Casalino LP, Kern LM, Grinspan ZM, Bao Y, Kaushal R.
2017.
Physician Participation in Meaningful Use and Quality of Care for Medicare Fee-for-Service Enrollees.. J Am Geriatr Soc. 65(3):608-613.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..
2019.
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.